Log in to access this content.
CMS Says IDRE Flagged With Potential Conflicts Meets Minimum Qualifications For IDRE Recertification
CMS says three Independent Dispute Resolution entities (IDREs) have met the minimum qualifications for recertification -- including one IDRE that stakeholders have flagged as potentially having ...
HHS is soliciting nominations for people knowledgeable about social and community aspects of immunization programs to serve on the Advisory Committee on Immunization Practices, the Centers for Disease ...
FDA published a proposed rule on infant formula nutrient requirements Thursday (Oct. 29) that would revise required levels of vitamins A and D and other ingredients, and announced its most recent ...
The House Oversight Committee is scrutinizing top pharmacy benefit managers’ recent audits of independent pharmacies, alleging the PBMs may have conducted audits in retaliation for the pharmacies’ ...
A coalition of dietary supplement trade groups is urging the National Institutes of Health to abandon a proposed reorganization that would move the Office of Dietary Supplements (ODS) under the agency ...
A Utah clinical artificial intelligence advisory group met this week as part of its ongoing effort to help bring clinical oversight to the state’s controversial AI health pilots by helping to draft ...
The General Services Administration and Anthropic have announced an agreement to make the frontier artificial intelligence developer’s Claude models available for use by federal, state and local ...
A group of attorneys is asking HHS to walk back a study it argues violates the department’s scientific integrity policies by tying support for gender-affirming care to political violence. The HHS ...
The top Democrats on the House Energy and Commerce, Science and Judiciary committees -- all poised to take chairmanships if the party wins the House in next week’s elections -- have written to five ...
HHS on Wednesday (Oct. 28) unveiled its much-anticipated interim peptide compounding policy, creating a temporary pathway for state-licensed pharmacies to compound six unapproved peptides while FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results